Area of research
Epidemiology · Molecular Biology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Endoplasmic Reticulum Stress and Disease, Peroxisome Proliferator-Activated Receptors, and interferon and immune responses.
TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase
Multispecies transcriptomics identifies SIKE as a MAPK repressor that prevents NASH progression.
Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP‐Activated Protein Kinase Signaling Pathway
Breviscapine alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling
Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling
A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques
A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques
Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis
Tumor Necrosis Factor α–Induced Protein 8–Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta–Activated Kinase 1 Activation
Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis
The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
Molecular Identification of <i>Diphyllobothrium nihonkaiense</i> from 3 Human Cases in Heilongjiang Province with a Brief Literature Review in China
Does D2 plus Para-Aortic Nodal Dissection surgery offer a better survival outcome compared to D2 surgery only for gastric cancer consistently? A definite result based on a hospital population of nearly two decades